Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>Clinical research &mdash; especially involving oncology trials &mdash; is evolving with the introduction of new therapies and therapeutic mechanisms. These raise new and sometimes challenging questions for IRBs reviewing the study protocols.</p>

Newest Oncology Studies Raise Ethical, Other Questions for IRBs

IRBs must stay on top of study design changes, experts say